Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

IMMUNOSET® p53/MDM2 complex ELISA development set

First ELISA development product for the measurement of the p53/MDM2 complex for apoptosis and autophagy research.
 
ADI-960-070 5x96 wells 515.00 USD
Do you need bulk/larger quantities?
 
  • Sensitive - detect picogram levels of the complex compared to microgram levels in Western blot
  • Accurate - validated against immunoprecipitation and Western blot
The IMMUNOSET® p53/MDM2 Complex ELISA development set contains sufficient reagents for the development of 5 x 96 well EIA plates which provides analysis of ~200 samples in duplicate. Save time, money, and sample by developing your own EIA kits. Simply coat your plates and go! This kit provides superior accuracy with fully quantitative results compared to Western blot analysis and has low reactivity with related molecules.
960-070-image
Please mouse over
960-070-image

Product Specification

Sensitivity:0.35 ng/ml p53 (range 0.78 - 50 ng/ml p53)
 
Assay Time:Plate Coating - Overnight + 1 hour; Assay - 3 hours
 
Applications:ELISA, Colorimetric detection
 
Application Notes:For the measurement of p53/MDM2 complex in cell lysates of human, mouse, and rat origin.
 
Species reactivity:Human, Mouse, Rat
 
Crossreactivity:This assay detects p53/MDM2 and does not show significant reactivity with human p21 or Bax.
 
Use/Stability:Store all components at +4°, except standard at -20°.
 
Shipping:Shipped on Blue Ice
 
Kit/Set Contains:Capture antibody, p53 Standard, MDM2 Standard, Detection antibody, SA-HRP
 
Scientific Background:The p53 tumor suppressor protein is a transcription factor that regulates a variety of biological functions including growth arrest, apoptosis, DNA repair, and differentiation. MDM2 is the principal antagonist of p53, and evidence suggests MDM2 gene amplification is found in about 7% of tumor tissues. MDM2 acts as an E3 ubiquitin ligase, cooperating with p300/CBP in the ubiquitination and subsequent proteosomal degradation of p53 in the cytoplasm and nucleus. Various strategies for cancer therapy involve activating the apoptotic and growth suppressive functions of p53 by disrupting its association with MDM25.
 
UniProt ID:P04637 (human p53), Q00987 (human MDM2)
 

Product Literature References

A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines: M.H. Visagie, et al.; Cell. Biosci. 5, 19 (2015), Application(s): Levels of p53/MDM2 in human breast cancer cell lines, Abstract; Full Text
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver: D.M. Ferreira, et al.; Mol. Cell. Biol. 34, 1100 (2014), Application(s): Levels of p53/MDM2 in primary rat hepatocytes, Abstract; Full Text

Related Literature

Brochures
Monitor programmed cell death from membrane to nucleus
Monitor programmed cell death from membrane to nucleus
Download as PDF

Catalogs
Immunoassay Kits
Immunoassay Kits
Download as PDF

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Brochures
Predictive Toxicology
Predictive Toxicology
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,